Pdt Partners, LLC Chroma Dex Corp. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.59 - $2.7 $43,316 - $73,556	-27,243 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $82,644 - $160,378	-40,913 Reduced 60.03%	27,243 $67,000
Q4 2021 Feb 14, 2022	BUY	$3.74 - $6.7 $30,477 - $54,598	8,149 Added 13.58%	68,156 $255,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $91,820 - $157,992	-15,177 Reduced 20.19%	60,007 $376,000
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $500,725 - $821,009	75,184 New	75,184 $741,000
Q1 2021 May 17, 2021	SELL	$4.59 - $18.74 $49,287 - $201,230	-10,738 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.93 - $5.5 $42,200 - $59,059	10,738 New	10,738 $52,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.